BRNS

Barinthus Biotherapeutics plc.CIK 1828185 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for BRNS PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for BRNS

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Hooftman Leon	Chief Medical Officer	10	$0	$0	2026-09-09
Oxford Science Enterprises plc	Other	2	$0	$0	2026-09-09
Scheeren Joseph	Director	14	$0	$0	2026-09-09
Wright Robin	Director	16	$0	$0	2026-09-09
Morgon Pierre A.	Director	16	$0	$0	2026-09-09
Hammacher Alex	Director	14	$0	$0	2026-09-09
Enright William	Chief Executive Officer, Director	16	$0	$0	2026-09-09
Phillips Anne M.	Director	14	$0	$0	2026-09-09
DAWES KAREN A	Director	14	$0	$0	2026-09-09
Brown Gemma	Chief Financial Officer	2	$0	$0	2025-02-03
Griffiths Graham	Chief Business Officer	2	$0	$0	2025-02-03
Pelletier Nadege	Chief Scientific Officer	1	$0	$0	2024-01-02

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer deriv	2026-09-09	2026-09-09	600,000	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer deriv	2026-09-09	2026-09-09	176,130	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer deriv	2026-09-09	2026-09-09	359,605	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer deriv	2026-09-09	2026-09-09	440,000	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer deriv	2026-09-09	2026-09-09	443,981	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer deriv	2026-09-09	2026-09-09	195,166	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer deriv	2026-09-09	2026-09-09	140,000	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,394	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	20,394	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer	2026-09-09	2026-09-09	1,700	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer	2026-09-09	2026-09-09	514,923	—	$0	0	SEC↗
Enright William	Chief Executive Officer	D To issuer	2026-09-09	2026-09-09	728,454	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer	2026-09-09	2026-09-09	3,000	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer	2026-09-09	2026-09-09	361,530	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	A Award	2026-09-09	2026-09-09	361,530	—	$0	361,530	SEC↗
Morgon Pierre A.	Director	D To issuer	2026-09-09	2026-09-09	10,506	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer	2026-09-09	2026-09-09	3,000	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer	2026-09-09	2026-09-09	23,000	—	$0	0	SEC↗
Wright Robin	Director	D To issuer	2026-09-09	2026-09-09	48,256	—	$0	0	SEC↗
Oxford Science Enterprises plc	Other	U Tender	2026-09-09	2026-09-11	8,797,770	$0.11	$967.8K	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Wright Robin	Director	D To issuer deriv	2026-09-09	2026-09-09	20,394	—	$0	0	SEC↗
Wright Robin	Director	D To issuer	2026-09-09	2026-09-09	48,256	—	—	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Scheeren Joseph	Director	D To issuer	2026-09-09	2026-09-09	23,000	—	—	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Phillips Anne M.	Director	D To issuer	2026-09-09	2026-09-09	3,000	—	—	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer deriv	2026-09-09	2026-09-09	20,394	—	$0	0	SEC↗
Morgon Pierre A.	Director	D To issuer	2026-09-09	2026-09-09	10,506	—	—	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer deriv	2026-09-09	2026-09-09	140,000	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer deriv	2026-09-09	2026-09-09	195,166	—	$0	0	SEC↗
Hooftman Leon	Chief Medical Officer	D To issuer	2026-09-09	2026-09-09	361,530	—	—	0	SEC↗
Hooftman Leon	Chief Medical Officer	A Award	2026-09-09	2026-09-09	361,530	—	—	361,530	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
Hammacher Alex	Director	D To issuer	2026-09-09	2026-09-09	3,000	—	—	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer deriv	2026-09-09	2026-09-09	600,000	—	$0	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer deriv	2026-09-09	2026-09-09	443,981	—	$0	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer deriv	2026-09-09	2026-09-09	440,000	—	$0	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer deriv	2026-09-09	2026-09-09	359,605	—	$0	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer deriv	2026-09-09	2026-09-09	176,130	—	$0	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer	2026-09-09	2026-09-09	514,923	—	—	0	SEC↗
Enright William	Chief Executive Officer, Dir	D To issuer	2026-09-09	2026-09-09	728,454	—	—	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	20,174	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	19,516	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	19,197	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	18,604	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer deriv	2026-09-09	2026-09-09	34,328	—	$0	0	SEC↗
DAWES KAREN A	Director	D To issuer	2026-09-09	2026-09-09	1,700	—	—	0	SEC↗
Oxford Science Enterprises plc	Other	U Tender	2026-09-09	2026-09-11	8,797,770	$0.11	$976.6K	0	SEC↗
DAWES KAREN A	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Scheeren Joseph	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Phillips Anne M.	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Morgon Pierre A.	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Wright Robin	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Hammacher Alex	Director	A Award deriv	2025-06-10	2025-06-11	20,174	—	$0	20,174	SEC↗
Hooftman Leon	Chief Medical Officer	A Award deriv	2025-02-03	2025-02-05	140,000	—	$0	140,000	SEC↗
Griffiths Graham	Chief Business Officer	A Award deriv	2025-02-03	2025-02-05	200,000	—	$0	200,000	SEC↗
Enright William	Chief Executive Officer	A Award deriv	2025-02-03	2025-02-05	600,000	—	$0	600,000	SEC↗
Brown Gemma	Chief Financial Officer	A Award deriv	2025-02-03	2025-02-05	160,000	—	$0	160,000	SEC↗
Hooftman Leon	Chief Medical Officer	A Award deriv	2024-06-03	2024-06-18	195,166	—	$0	195,166	SEC↗
Wright Robin	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
Morgon Pierre A.	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
Hammacher Alex	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
Phillips Anne M.	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
Scheeren Joseph	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
DAWES KAREN A	Director	A Award deriv	2024-05-10	2024-05-14	19,516	—	$0	19,516	SEC↗
Brown Gemma	Chief Financial Officer	A Award deriv	2024-01-02	2024-01-04	193,000	—	$0	193,000	SEC↗
Enright William	Chief Executive Officer	A Award deriv	2024-01-02	2024-01-04	443,981	—	$0	443,981	SEC↗
Griffiths Graham	Chief Business Officer	A Award deriv	2024-01-02	2024-01-04	96,500	—	$0	96,500	SEC↗
Pelletier Nadege	Chief Scientific Officer	A Award deriv	2024-01-02	2024-01-04	105,000	—	$0	105,000	SEC↗